Literature DB >> 8924249

Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the amsterdam population.

C L Kuiken1, V V Lukashov, E Baan, J Dekker, J A Leunissen, J Goudsmit.   

Abstract

OBJECTIVE: To study the development of the V3 region of the HIV-1 envelope over time, both within subjects and population-wide.
METHODS: Direct V3 sequences were obtained from viral RNA from seroconversion samples of 138 individuals [32 intravenous drug users (IVDU), 106 homosexual men], as well as from 5-year follow-up samples of 45 of these individuals (11 IVDU, 34 homosexual men).
RESULTS: The population-wide variation of the V3 region in both the seroconversion samples and the 5-year samples steadily increased over consecutive years and were of similar magnitude in each calendar year. The variation in the IVDU group was slightly lower (presumably lagging behind) than in the homosexual group, but also increased over time. The consensus sequence, representing the centre of the swarm of variants, remained almost stationary in 10 years of evolution. The V3 sequences from virions in serum collected 5 years after seroconversion still resembled those from the seroconversion sample, either in overall similarity or in specific (signature) amino acids. Seroconversion and late sequences from a donor-recipient pair were also very similar.
CONCLUSIONS: The variation in V3 sequences from seroconversion samples is as large as that in 5-year follow-up samples from the same calendar year, suggesting that there is no strong selection for a particular V3 genotype at transmission. The HIV-1 subtype B quasispecies in a naive population appears to evolve through unbiased expansion around a stationary consensus sequence. Despite its large variability, the V3 region retains many of its individual characteristics after 5 years of infection. This indicates that the sampling moment (relative to the seroconversion data) will not greatly influence the results of phylogenetic analyses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8924249     DOI: 10.1097/00002030-199601000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

Review 1.  Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.

Authors:  J P Moore; P W Parren; D R Burton
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago.

Authors:  F R Cleghorn; N Jack; J K Carr; J Edwards; B Mahabir; A Sill; C B McDanal; S M Connolly; D Goodman; R Q Bennetts; T R O'Brien; K J Weinhold; C Bartholomew; W A Blattner; M L Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

3.  Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution?

Authors:  V V Lukashov; J Goudsmit
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo.

Authors:  L Zhang; R S Diaz; D D Ho; J W Mosley; M P Busch; A Mayer
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Evolution of the human immunodeficiency virus type 1 subtype-specific V3 domain is confined to a sequence space with a fixed distance to the subtype consensus.

Authors:  V V Lukashov; J Goudsmit
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Real-time PCR assay of individual human immunodeficiency virus type 1 variants in coinfected human lymphoid tissues.

Authors:  Yoshinori Ito; Jean-Charles Grivel; Leonid Margolis
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.

Authors:  L Zhang; T He; Y Huang; Z Chen; Y Guo; S Wu; K J Kunstman; R C Brown; J P Phair; A U Neumann; D D Ho; S M Wolinsky
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infection.

Authors:  Linqi Zhang; Leslie Rowe; Tian He; Chris Chung; Jian Yu; Wenjie Yu; Andrew Talal; Marty Markowitz; David D Ho
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Unequal evolutionary rates in the human immunodeficiency virus type 1 (HIV-1) pandemic: the evolutionary rate of HIV-1 slows down when the epidemic rate increases.

Authors:  Irina Maljkovic Berry; Ruy Ribeiro; Moulik Kothari; Gayathri Athreya; Marcus Daniels; Ha Youn Lee; William Bruno; Thomas Leitner
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

10.  Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Authors:  James M Binley; Terri Wrin; Bette Korber; Michael B Zwick; Meng Wang; Colombe Chappey; Gabriela Stiegler; Renate Kunert; Susan Zolla-Pazner; Hermann Katinger; Christos J Petropoulos; Dennis R Burton
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.